Fenoldopam as a Possible Medication for Non-Occlusive Mesenteric Ischemia (NOMI) and Contrast-Induced Nephropathy?

Authors

  • Mirza Mehmood Ali Baig Dow University of Health and Science
  • Ramish Sumbal Dow University of Health and Science
  • Shayan Ali Irfan Dow University of Health and Science
  • Jawad Ahmed Dow University of Health and Science

Keywords:

Non occlusive mesenteric Ischemia, Fenoldopam, CT scan, contrast-induced nephropathy

Abstract

Abstract not available

Bangladesh Journal of Infectious Diseases 2021;8(1):53-54

Abstract
241
PDF
321

Author Biographies

Ramish Sumbal, Dow University of Health and Science

Internal Medicine and Student

Shayan Ali Irfan, Dow University of Health and Science

Internal Medicine and StudentĀ 

Jawad Ahmed, Dow University of Health and Science

Internal Medicine and House Officer

Downloads

Published

2022-01-30

Issue

Section

Letter to Editor

How to Cite

Baig, M. M. A., Sumbal, R., Irfan, S. A., & Ahmed, J. (2022). Fenoldopam as a Possible Medication for Non-Occlusive Mesenteric Ischemia (NOMI) and Contrast-Induced Nephropathy?. Bangladesh Journal of Infectious Diseases, 8(1), 53-54. https://doi.org/10.3329/bjid.v8i1.53742